A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
Clinical trial NCT06866405 · RECRUITING
Trial details
- NCT number
- NCT06866405
- Sponsor
- Pfizer
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-16
- Primary completion
- 2028-02-24
- Enrollment
- 550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.